Yi Cai

5.9k total citations
125 papers, 4.5k citations indexed

About

Yi Cai is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Yi Cai has authored 125 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Molecular Biology, 53 papers in Pulmonary and Respiratory Medicine and 27 papers in Cancer Research. Recurrent topics in Yi Cai's work include Prostate Cancer Treatment and Research (35 papers), Prostate Cancer Diagnosis and Treatment (18 papers) and Cancer-related molecular mechanisms research (12 papers). Yi Cai is often cited by papers focused on Prostate Cancer Treatment and Research (35 papers), Prostate Cancer Diagnosis and Treatment (18 papers) and Cancer-related molecular mechanisms research (12 papers). Yi Cai collaborates with scholars based in China, United States and United Kingdom. Yi Cai's co-authors include Michael Ittmann, Jianghua Wang, Mingyao Liu, Chengxi Ren, Gregory R. Dressler, Lewis J. Stafford, Kwang‐Wook Choi, Ya‐Chieh Hsu, Joshua J. Chern and Guillermo Oliver and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Yi Cai

120 papers receiving 4.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yi Cai China 35 2.7k 1.4k 990 713 567 125 4.5k
Jaume Reventós Spain 42 2.1k 0.8× 1.1k 0.8× 1.2k 1.2× 995 1.4× 632 1.1× 141 4.7k
Uma Chandran United States 33 2.3k 0.8× 898 0.6× 1.3k 1.3× 852 1.2× 456 0.8× 96 4.1k
Shahriar Koochekpour United States 34 2.2k 0.8× 912 0.7× 979 1.0× 723 1.0× 283 0.5× 84 3.8k
Anna Bagnato Italy 46 3.3k 1.2× 897 0.6× 1.0k 1.0× 1.4k 2.0× 459 0.8× 124 6.2k
Takao Takahashi Japan 33 2.6k 0.9× 1.0k 0.7× 557 0.6× 1.6k 2.2× 395 0.7× 189 5.1k
Christopher M. Hovens Australia 38 1.8k 0.7× 852 0.6× 593 0.6× 550 0.8× 255 0.4× 121 3.9k
Gaëlle Fromont France 35 1.7k 0.6× 2.0k 1.4× 622 0.6× 825 1.2× 356 0.6× 163 4.8k
Mitsutoshi Nakamura Japan 38 2.4k 0.9× 565 0.4× 849 0.9× 1.1k 1.6× 231 0.4× 151 4.5k
Jeffrey R. Gingrich United States 26 1.5k 0.5× 1.1k 0.8× 502 0.5× 796 1.1× 380 0.7× 78 3.3k
Yuh‐Shan Jou Taiwan 36 2.7k 1.0× 440 0.3× 908 0.9× 791 1.1× 393 0.7× 78 3.9k

Countries citing papers authored by Yi Cai

Since Specialization
Citations

This map shows the geographic impact of Yi Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Cai more than expected).

Fields of papers citing papers by Yi Cai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Cai. The network helps show where Yi Cai may publish in the future.

Co-authorship network of co-authors of Yi Cai

This figure shows the co-authorship network connecting the top 25 collaborators of Yi Cai. A scholar is included among the top collaborators of Yi Cai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi Cai. Yi Cai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zhang, Qian, et al.. (2026). Structure-Based Virtual Screening Discovers Potent PLK1 Inhibitors with Anticancer Activity. Journal of Chemical Information and Modeling. 66(2). 1050–1066.
3.
4.
Wang, Yinzhao, Yan Yang, Lin Qi, et al.. (2025). Early prediction of response to ADT plus ARPIs in mHSPC using interpretable machine learning on PSMA PET/CT: a real-world study. European Journal of Nuclear Medicine and Molecular Imaging. 53(5). 3007–3022.
5.
Zhang, Honghu, Lin Qi, Yi Cai, & Xiaomei Gao. (2024). Gastrin-releasing peptide receptor (GRPR) as a novel biomarker and therapeutic target in prostate cancer. Annals of Medicine. 56(1). 2320301–2320301. 12 indexed citations
6.
Wang, Xingming, Lin Qi, Minfeng Chen, et al.. (2024). Feasibility study of ADCs targeting TROP-2, HER2, and CD46 in Ductal Adenocarcinoma and Intraductal Carcinoma of the prostate. World Journal of Urology. 42(1). 404–404. 1 indexed citations
7.
Liu, Jing, Xiaomei Gao, Jiaxian Chen, et al.. (2023). circWSB1 promotes tumor progression in ccRCC via circWSB1/miR-182-5p/WSB1 axis. International Journal of Biological Macromolecules. 256(Pt 1). 128338–128338. 4 indexed citations
8.
Tham, Cheng Yong, Lai-Fong Poon, Tingdong Yan, et al.. (2023). High-throughput telomere length measurement at nucleotide resolution using the PacBio high fidelity sequencing platform. Nature Communications. 14(1). 281–281. 27 indexed citations
9.
Wang, Li, Yurong Cheng, Jing Yang, et al.. (2022). Case Report: Addition of PD-1 Antibody Camrelizumab Overcame Resistance to Trastuzumab Plus Chemotherapy in a HER2-Positive, Metastatic Gallbladder Cancer Patient. Frontiers in Immunology. 12. 784861–784861. 6 indexed citations
10.
11.
Luo, Cong, Yushi Zhang, Mingxin Zhang, et al.. (2021). Everolimus versus sirolimus for angiomyolipoma associated with tuberous sclerosis complex: a multi-institutional retrospective study in China. Orphanet Journal of Rare Diseases. 16(1). 299–299. 11 indexed citations
12.
13.
Cai, Yi, Hanzhong Li, & Yushi Zhang. (2017). Assessment of Tuberous Sclerosis Complex Associated With Renal Lesions by Targeted Next-generation Sequencing in Mainland China. Urology. 101. 170.e1–170.e7. 16 indexed citations
14.
Huang, Haiying, et al.. (2016). Comparative study on common diagnostic methods for covert hepatic encephalopathy. Zhonghua xiaohua zazhi. 36(10). 692–697. 1 indexed citations
15.
Skor, Maxwell N., Masha Kocherginsky, Anju Goyal, et al.. (2013). Glucocorticoid Receptor Antagonism as a Novel Therapy for Triple-Negative Breast Cancer. Clinical Cancer Research. 19(22). 6163–6172. 152 indexed citations
16.
Wang, Jianghua, Yi Cai, Longjiang Shao, et al.. (2010). Activation of NF-κB by TMPRSS2/ERG Fusion Isoforms through Toll-Like Receptor-4. Cancer Research. 71(4). 1325–1333. 66 indexed citations
17.
Cai, Yi, Jianghua Wang, Rile Li, et al.. (2009). GGAP2/PIKE-A Directly Activates Both the Akt and Nuclear Factor-κB Pathways and Promotes Prostate Cancer Progression. Cancer Research. 69(3). 819–827. 34 indexed citations
18.
Yan, Jun, Halime Erdem, Rile Li, et al.. (2008). Steroid Receptor Coactivator-3/AIB1 Promotes Cell Migration and Invasiveness through Focal Adhesion Turnover and Matrix Metalloproteinase Expression. Cancer Research. 68(13). 5460–5468. 90 indexed citations
19.
Wang, Jianghua, Yi Cai, Wendong Yu, et al.. (2008). Pleiotropic Biological Activities of Alternatively Spliced TMPRSS2/ERG Fusion Gene Transcripts. Cancer Research. 68(20). 8516–8524. 130 indexed citations
20.
Cai, Yi, Ángeles Álvarez, Pilar Alcaide, et al.. (2006). Abrogation of Functional Selectin-Ligand Expression Reduces Migration of Pathogenic CD8+ T Cells into Heart. The Journal of Immunology. 176(11). 6568–6575. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jaume Reventós Breakdown of academic impact, for papers by Uma Chandran Breakdown of academic impact, for papers by Shahriar Koochekpour Breakdown of academic impact, for papers by Anna Bagnato Breakdown of academic impact, for papers by Takao Takahashi Breakdown of academic impact, for papers by Christopher M. Hovens Breakdown of academic impact, for papers by Gaëlle Fromont Breakdown of academic impact, for papers by Mitsutoshi Nakamura Breakdown of academic impact, for papers by Jeffrey R. Gingrich Breakdown of academic impact, for papers by Yuh‐Shan Jou
Rankless by CCL
2026